|Year : 2019 | Volume
| Issue : 1 | Page : 27-33
Examining depression and quality of life in patients with thalassemia in Sri Lanka
Priya Patel1, Paul Beamish1, Tricia L da Silva2, Dewmi Kaushalya3, Anuja Premawardhena3, Shehan Williams3, Arun V Ravindran2
1 Department of Psychiatry, University of Toronto, Toronto, Canada
2 Department of Psychiatry, University of Toronto; Centre for Addiction and Mental Health, Toronto, Canada
3 Department of Psychiatry, University of Kelaniya, Ragama, Sri Lanka
|Date of Web Publication||18-Mar-2019|
Dr. Arun V Ravindran
Centre for Addiction and Mental Health, 100 Stokes St., Toronto M6J 1H4
Source of Support: None, Conflict of Interest: None
Background: With more effective treatments and improved outcomes in thalassemia, there is increasing focus on its psychological sequelae. Most published data on this topic are from high-income countries and much less so from low- and middle-income countries, where thalassemia is more prevalent.
Aim: The aim of this study was to systematically evaluate the psychiatric morbidity and quality of life in relation to demographic- and illness-related variables among Sri Lankan patients with thalassemia.
Methods: This cross-sectional investigation was conducted at the University of Kelaniya Teaching Hospital in Sri Lanka. Patients with all forms of thalassemia, over 12 years of age, and in stable medical condition (n = 120) were recruited. Assessment tools included a general demographic questionnaire, the Beck Depression Inventory-II, and the World Health Organization Quality of Life Measure–Brief. Statistical analysis was conducted using linear regressions, Chi-squares, and analyses of variance.
Results: Lack of family support, longer duration of inpatient admission, and female gender were associated with higher depression scores and reduced quality of life. Environmental and social quality of life were positively correlated with levels of peer support in males, while increased support from religion correlated with lower depression scores and higher satisfaction with environmental and psychological quality of life in women. There was no association between the type of thalassemia and either depression or quality of life measures.
Conclusion: Several factors may influence the psychological state and well-being of patients with thalassemia in Sri Lanka. Specific service innovations (some gender-specific) may help to address these factors to improve treatment outcome and well-being.
Keywords: Depression, quality of life, Sri Lanka, thalassemia
|How to cite this article:|
Patel P, Beamish P, da Silva TL, Kaushalya D, Premawardhena A, Williams S, Ravindran AV. Examining depression and quality of life in patients with thalassemia in Sri Lanka. Int J Non-Commun Dis 2019;4:27-33
|How to cite this URL:|
Patel P, Beamish P, da Silva TL, Kaushalya D, Premawardhena A, Williams S, Ravindran AV. Examining depression and quality of life in patients with thalassemia in Sri Lanka. Int J Non-Commun Dis [serial online] 2019 [cited 2022 May 21];4:27-33. Available from: https://www.ijncd.org/text.asp?2019/4/1/27/254491
| Introduction|| |
Thalassemias are a group of genetic disorders caused by a mutation to the globin chains resulting in decreased hemoglobin (Hb) synthesis. Worldwide, the prevalence of thalassemias ranges from 0 to 19%, with highest rates in Southeast Asia, the Eastern Mediterranean (particularly Cyprus and Sardinia), and Sub-Saharan Africa.,
Patients with thalassemia often present with a range of clinical presentations depending on the severity of the globin chain mutation. Such variations may also influence their management including specific pharmacotherapy. Within the category of β-subunit affected thalassemias, individuals with β-thalassemia major have the most severe form of the disorder, with a homozygous inheritance of a nonfunctional β-globin subunit. β-thalassemia major often results in severe anemia and physical and facial deformities and requires regular blood transfusions and chelation therapy. In comparison, patients with β-thalassemia minor have the least severe form due to a heterozygous inheritance of the abnormal β-globin gene and can often be asymptomatic throughout their entire adult life. Nontransfusion-dependent thalassemia is a term used to identify a group of disorders which are of intermediate severity, and as the name implies, these individuals can survive without regular blood transfusions. The clinical spectrum of this group varies immensely, and in this cluster are the “classic” β-thalassemia intermedia, Hb E β-thalassemia and Hb H disease, as well as sickle cell β-thalassemia traits.
Individuals with thalassemia often experience severe challenges and life stressors that contribute to psychological distress, namely, the impact of symptoms, severity and adverse effects of treatment, physical and facial deformities, as well as the risk of increased mortality., Furthermore, they experience social, educational as well as occupational challenges and being often separated from their families to access care. Previous research in countries, including Iran, Turkey, Egypt, Lebanon, and Italy, has found increased levels of depression in patients with thalassemia.,,,, These patients have also been found to have poor physical- and mental health-related quality of life, increased levels of pain, and impaired sleep, vitality, and social function. Furthermore, a recent study documents the significant psychological problems experienced by transitional youth with thalassemia and the likelihood of adverse long-term impact. These findings strongly support the need for an integrated psychosocial program that includes screening of psychiatric disorders to be part of the overall management of these patients.
| Methods|| |
This cross-sectional descriptive study was conducted at the Adolescent and Adult Thalassemia Care Unit of the University of Kelaniya Teaching Hospital in Ragama. This is the only thalassemia unit that treats adults with this illness in the country and is responsible for approximately 300 patients. The study was conducted with ethics approval from the Faculty of Medicine at the University of Kelaniya. Patients with a clinical diagnosis of thalassemia (major and intermedia) confirmed by high-performance liquid chromatography and genetic analysis were included in the study. The differentiation between thalassemia major and intermedia was based on the age of presentation and transfusion history. Patients who needed more than eight transfusions per year were classified as thalassemia major, and those with lesser requirements were considered as thalassemia intermedia.
Patients on the thalassemia unit were approached to participate in the study. Patients ≥12 years of age, in stable medical condition, and able to communicate effectively in Sinhalese, Tamil, or English, were eligible for inclusion. Patients were excluded from participation if they did not meet these criteria, if they suffered from an altered state of consciousness, or if they refused consent.
Patients were presented with a consent letter, information leaflet, and an oral briefing from trained medical personnel to understand the purpose of the study, risk and benefits of participation, and participant responsibilities. Written consent was obtained from all patients who participated in the study, as well as from parents of child or adolescent patients (between 12 and 18 years of age). Enrolled participants then completed a series of self-report questionnaires.
A general questionnaire was devised to gather basic demographic information (age, gender, hometown, highest educational level attained, household income, primary caregiver, and religious affiliation) and illness-related data (diagnosis, length of stay/admission in unit, and details on other affected family members).
The self-administered 4-point Likert scale was used to obtain information about their support network, for example, the strength of support they receive ("Do you feel well supported by __?") from their family, peers, hospital staff, and religion, where 0 = never, 1 = sometimes, 2 = most of the time, and 3 = all the time.
Presence and severity of depression were assessed using the 21-item Beck Depression Inventory (BDI-II). Items on this self-rated questionnaire are rated on a 4-point Likert scale, where higher total scores correspond to greater severity of depression. To make accommodations for those under 18 years and for cultural sensitivity, question 21 (which asks about sexual activity) was eliminated and the total score rating scale was adjusted to accommodate this change.
The World Health Organization Quality of Life–Brief (WHOQOL-BREF) was used to assess the quality of life domains including physical health, psychological health, social relationships, and environment. This 26-item self-administered questionnaire is a shorter version of the WHOQOL-100 and was used due to time restrictions and to minimize the burden on the patient. Items were rated on a 5-point scale from which a raw item score is transformed into a mean score per domain between 0 and 100, where a higher score indicates to a better quality of life.
Statistical analysis was performed using IBM SPSS Version 23, (Armonk, New York, United States). Student's t-tests were performed on the survey questions to identify differences in response value within each question. One-way analyses of variance and Chi-squared analyses were performed to identify correlations and group differences. Linear regression was used to predict depressive severity on the BDI-II and satisfaction with physical health, psychological well-being, social relationships, and environment. Demographic factors were used as the independent variables, with the BDI-II and WHOQOL-BREF scores used as the dependent variables. Level of formal education was treated as an ordinal variable, income was analyzed as an interval variable, and type of thalassemia diagnosis was evaluated as a categorical variable. P ≤ 0.05 was considered statistically significant for all analyses.
| Results|| |
Participant demographics can be found in [Table 1]. The study population consisted of 138 patients, with 59.2% having thalassemia major, 21.7% having Hb E β-thalassemia, 9.2% having thalassemia intermedia, 3.3% having thalassemia minor, 0.8% having Hb S β-thalassemia, and 4.2% having other inherited blood disorders. Across the sample, 53.6% were female and 77.8% were ≥18 years of age (range 12–65 years).
|Table 1: Demographic characteristics of participants from the Hemals Thalassemia Clinic|
Click here to view
The results of the linear regression analyses are summarized in [Table 2], [Table 3], [Table 4]. For the patient's sample as a whole [Table 2], increased age significantly predicted reduced satisfaction with social relationships (P = 0.01), while female gender was associated with higher depression scores (P = 0.05) and lower satisfaction with physical health (P = 0.02), psychological health (P = 0.03), and social relationships (P = 0.007). Longer duration of inpatient stay predicted more severe depression (P = 0.03) and lower satisfaction with physical health (P = 0.03). More family support predicted lower depression (P = 0.004) and more satisfaction with environment (P < 0.0005) and physical health (P = 0.02). Similarly, increased peer support was also associated with more satisfaction with physical health (P = 0.04) and social relationships (P = 0.04).
|Table 2: Linear regression of predictors of depression and quality of life parameters in the full participant sample (n=138)|
Click here to view
|Table 3: Linear regression of predictors of depression and quality of life parameters among female participants (n=74)|
Click here to view
|Table 4: Linear regression model of predictors of depression and quality of life parameters among male participants (n=64)|
Click here to view
Additional regression analyses were conducted separately for males and females to determine if there were gender differences in predictors of outcomes.
For females [Table 3], higher household income was a significant predictor of more satisfaction with social relationships (P = 0.02). Those with thalassemia intermedia diagnosis had lower satisfaction with environment than those with thalassemia major diagnosis (P = 0.05). Longer length of stay predicted higher depression scores (P = 0.04). Higher family support predicted increased satisfaction with environment (P = 0.001), physical health (P = 0.03), and psychological health (P = 0.002). Increased support from religious beliefs predicted lower depression scores (P = 0.05) and higher satisfaction with environment (P = 0.04) and psychological health (P = 0.01).
For males [Table 4], those with thalassemia intermedia diagnosis had more satisfaction with psychological well-being than those with thalassemia major diagnosis (P = 0.05). Greater family support predicted lower depression (P = 0.001) and being more satisfied with their environment (P = 0.009). High degree of peer support predicted greater satisfaction with environmental (P = 0.02) and social relationships (P = 0.02).
Patient's level of formal education and degree of hospital staff support were not found to be related to mental health outcomes in any analyses (P > 0.05).
| Discussion|| |
As with other early-onset chronic diseases, psychological health and day-to-day function are adversely affected by thalassemia itself as well as factors related to its treatment. As newer treatment strategies have improved outcomes of physical symptoms, there is an increased focus on emotional well-being of these patients.
We found that these patients, as a group, had higher depression scores and poorer quality of life scores. This finding is consistent with reports from several other low- and middle-income countries,,, which have concluded that thalassemia was associated with increased risk of depression and lower quality of life. We found that the presence of emotional symptoms and reduced quality of life was associated with being female, a longer clinic exposure, and lack of family support. The finding that females have greater vulnerability to depression compared to males is a well-documented finding worldwide, including Sri Lanka. Several reasons have been proposed for this gender difference, including genetic predisposition, psychological factors, and increased vulnerability to stress. The association of longer duration of treatment with higher depression scores is intuitive and consistent with reports from Western countries that have reported a direct correlation between psychiatric morbidity and length of hospital stay., As with our finding, such reports have also noted the association of poor family support with increased likelihood of depression and decreased quality of life. Indeed, based on the expectations in family relationships and cultural practices in Sri Lanka, it can be suggested that the impact of poor family support may be even greater on the psychological state of these patients. It has been previously proposed that including family members in patient care during inpatient admission may aid in the management of depression, improve the quality of life, and thus contribute to recovery.
The thalassemia service had separate inpatient units for men and women, which enabled behavioral observations to be documented in the two groups. The men often socialized more with their peers by coming together during the day and playing games or sharing stories, while the females were quieter and tended to be more solitary. To determine if these differences were also reflected in overall outcome and illness trajectory, the study variables were also analyzed by gender. The results suggested that the degree of peer support was a significant predictor of depression severity among male patients, but not among female patients. Interestingly, higher peer support was also associated with greater satisfaction with environment and social relationships but only in men. This finding is consistent with other studies, which have found social support to be a protective factor against depression in both youth and adults.,,,,
It is unclear why peer support did not have similar benefits for women in our study, but a possible explanation is that the tendency of the female patients toward solitude and/or less social interaction reduced the potential for benefit from such support. An alternate explanation is that the social support women received by women may be inadequate, inappropriate, or maladaptive. It has been previously reported that although social support is protective against depression for both males and females,, the degree of benefit may vary depending on the type of support. Positive or helpful social support lowers rates of depression, whereas support, that is, perceived as superficial or is accompanied by support needs of the supporting person has an adverse impact on depression. Further evaluations of the type of social support received by females with thalassemia and the development of appropriate peer support groups that use evidence-based approaches may contribute to the therapeutic benefit of the milieu in the inpatient units.
Furthermore, our study found that support from religious beliefs predicted lower depression and higher satisfaction with environment and psychological health among female patients, but not in males. This is in line with the literature, which notes that females are more likely to depend on religious beliefs to cope with stressful situations than males. This finding (together with the noted benefit of peer support in men) supports the strategy of unique, gender-based psychosocial interventions. Thus, emphasis on peer inclusion and social events, as well as the availability of sanctioned religious celebrations and prayer time and meditative practices may contribute to psychological well-being.
We noted that scores on certain items of the BDI-II in our study population differed compared to historical reports in the Western, nonthalassemic literature., The study patients reported experiencing certain symptoms infrequently, such as feelings of failure and thoughts of suicide. They also reported low frequency of anhedonia, irritability, and poor concentration. However, the levels of self-blame and guilt were high, as were episodes of crying and sleep impairment. Of these, a tendency for crying remained a highly scored response for both genders, which goes against the finding in published literature of major depressive disorder (MDD) which reports females to have an increased frequency of crying when compared to males and weeping in females was seen as a form of coping. Clinicians in Sri Lanka confidentially report seeing these differences and attribute it to be a cultural phenomenon. We also found that females had higher scores of self-criticism and guilt compared to males, in keeping with published literature that women with depression tend to express more self-blame than men. Psychological therapies often focus on guilt and self-criticism as a key symptom to address. In this context, it would be essential to address any gender and cultural bias when developing or adopting psychological interventions for Sri Lankan patients.
While previous studies have reported the significant presence of depression in patients with thalassemia, they did not explore any differences among subtypes (major, minor, and intermedia) of the condition.,,, We found no difference between the three subtypes in the severity of depression or their quality life measures. This was unexpected as the thalassemia major tends to have greater disease burden. This finding may be explained, at least in part, by the variance in diagnosis-related treatment regimens. In general, patients with thalassemia major are treated quite aggressively in accordance with the severity of the disease, while guidelines are less defined for those with thalassemia intermedia or minor. Often, the treatment of patients with thalassemia intermedia or E/β-thalassemia is left to clinical discretion, which can have varying outcomes. That is, it is possible that their medical management may not be as rigorous compared to thalassemia major, contributing to chronicity of symptoms and resulting in impaired quality of life. It is suggested that development of evidence-based algorithms and guidelines for treating the intermedia and minor subtypes of thalassemia may contribute to better understanding of the psychological sequela in this population and lead to better overall outcomes.
Several limitations of this investigation are acknowledged. A key deficiency is the lack of accompanying qualitative data, which likely would have captured the personal, subjective experiences of patients and provided additional measures of psychological distress. It is noted that it is a cross-sectional investigation conducted in a single specialized center, the Adolescent and Adult Thalassemia Care Unit. It serves as the national resource providing comprehensive, specialized care for thalassemia patients. Thus, the findings for this investigation may not be generalizable to Sri Lanka as a whole or to other countries with similar socioeconomic profile in the region. Finally, a methodological deficiency is the lack of syndromal diagnosis of depression (e.g., DSM 5 (Diagnostic and Statistical Manual of Mental Disorders, 5th edition) or International Statistical Classification of Disease II) using a validated interview, the presence of depression with diagnostic cutoffs was not evaluated, and therefore, the prevalence of DSM-5 depression was not documented in our sample.
| Conclusion|| |
This study suggests that certain patient factors are associated with higher depressive scores and poorer quality of life in patients with thalassemia. Modification of treatment interventions, such as by capitalizing on the positive benefits of family, peer, and religious support, could help alleviate psychiatric morbidity, improve function, and reduce disability in this population. Adaptation of psychological interventions based on gender may also be useful.
We would like to thank all of the wonderful physicians, nurses, medical trainees, and all other members of the Adolescent and Adult Thalassemia Care Unit of the University of Kelaniya Teaching Hospital in Ragama. All of their incredible help and hospitality allowed us to conduct this research project and have a great experience during our time in Sri Lanka.
Financial support and sponsorship
The study was partly supported by the International Health CREMS Undergraduate Summer Research Scholarships to P.P. and P.B. The financial support from the University of Toronto Medical Alumni Association and the Dr. Elva May Rowe Fund is thankfully acknowledged.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Yengil E, Acipayam C, Kokacya MH, Kurhan F, Oktay G, Ozer C, et al.
Anxiety, depression and quality of life in patients with beta thalassemia major and their caregivers. Int J Clin Exp Med 2014;7:2165-72.
Shafiee A, Nazari S, Jorjani S, Bahraminia E, Sadeghi-Koupaei M. Prevalence of depression in patients with β-thalassemia as assessed by the Beck's depression inventory. Hemoglobin 2014;38:289-91.
Keşkek SO, Kirim S, Turhan A, Turhan FG. Depression in subjects with beta-thalassemia minor. Ann Hematol 2013;92:1611-5.
Yahia S, El-Hadidy MA, El-Gilany AH, Anwar R, Darwish A, Mansour AK, et al.
Predictors of anxiety and depression in Egyptian thalassemic patients: A single center study. Int J Hematol 2013;97:604-9.
Khoury B, Musallam KM, Abi-Habib R, Bazzi L, Ward ZA, Succar J, et al.
Prevalence of depression and anxiety in adult patients with β-thalassemia major and intermedia. Int J Psychiatry Med 2012;44:291-303.
Messina G, Colombo E, Cassinerio E, Ferri F, Curti R, Altamura C, et al.
Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med 2008;3:339-43.
Pradhan PV, Shah H, Rao P, Ashturkar D, Ghaisas P. Psychopathology and self-esteem in chronic illness. Indian J Pediatr 2003;70:135-8.
Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr 2007;74:727-30.
de Silva S, Fisher CA, Premawardhena A, Lamabadusuriya SP, Peto TE, Perera G, et al.
Thalassaemia in Sri Lanka: Implications for the future health burden of Asian populations. Sri Lanka thalassaemia study group. Lancet 2000;355:786-91.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med 1998;28:551-8.
Azarkeivan A, Hajibeigi B, Alavian SM, Lankarani MM, Assari S. Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia. J Res Med Sci 2009;14:349-55.
Hajibeigi B, Azarkeyvan A, Alavian SM, Lankarani MM, Assari S. Anxiety and depression affects life and sleep quality in adults with beta-thalassemia. Indian J Hematol Blood Transfus 2009;25:59-65.
Rodrigo C, Welgama S, Gurusinghe J, Wijeratne T, Jayananda G, Rajapakse S, et al.
Symptoms of anxiety and depression in adolescent students; a perspective from Sri Lanka. Child Adolesc Psychiatry Ment Health 2010;4:10.
Noble RE. Depression in women. Metabolism 2005;54:49-52.
Ball HA, Sumathipala A, Siribaddana SH, Kovas Y, Glozier N, McGuffin P, et al.
Genetic and environmental contributions to depression in Sri Lanka. Br J Psychiatry 2009;195:504-9.
Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, et al.
Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 2002;20:1907-17.
Saravay SM, Steinberg MD, Weinschel B, Pollack S, Alovis N. Psychological comorbidity and length of stay in the general hospital. Am J Psychiatry 1991;148:324-9.
Väänänen JM, Marttunen M, Helminen M, Kaltiala-Heino R. Low perceived social support predicts later depression but not social phobia in middle adolescence. Health Psychol Behav Med 2014;2:1023-37.
Heponiemi T, Elovainio M, Kivimäki M, Pulkki L, Puttonen S, Keltikangas-Järvinen L, et al.
The longitudinal effects of social support and hostility on depressive tendencies. Soc Sci Med 2006;63:1374-82.
Newman BM, Newman PR, Griffen S, O'Connor K, Spas J. The relationship of social support to depressive symptoms during the transition to high school. Adolescence 2007;42:441-59.
Newsom JT, Schulz R. Social support as a mediator in the relation between functional status and quality of life in older adults. Psychol Aging 1996;11:34-44.
Blixen CE, Kippes C. Depression, social support, and quality of life in older adults with osteoarthritis. Image J Nurs Sch 1999;31:221-6.
Santini ZI, Fiori KL, Feeney J, Tyrovolas S, Haro JM, Koyanagi A, et al.
Social relationships, loneliness, and mental health among older men and women in Ireland: A prospective community-based study. J Affect Disord 2016;204:59-69.
Kendler KS, Myers J, Prescott CA. Sex differences in the relationship between social support and risk for major depression: A longitudinal study of opposite-sex twin pairs. Am J Psychiatry 2005;162:250-6.
Revenson TA, Schiaffino KM, Majerovitz SD, Gibofsky A. Social support as a double-edged sword: The relation of positive and problematic support to depression among rheumatoid arthritis patients. Soc Sci Med 1991;33:807-13.
Brown JS, Cherry KE, Marks LD, Jackson EM, Volaufova J, Lefante C, et al.
After hurricanes Katrina and Rita: Gender differences in health and religiosity in middle-aged and older adults. Health Care Women Int 2010;31:997-1012.
De Fruyt F. Gender and individual differences in adult crying. Pers Individ Dif 1997;22:937-40.
Luyten P, Sabbe B, Blatt SJ, Meganck S, Jansen B, De Grave C, et al.
Dependency and self-criticism: Relationship with major depressive disorder, severity of depression, and clinical presentation. Depress Anxiety 2007;24:586-96.
Aydin B, Yaprak I, Akarsu D, Okten N, Ulgen M. Psychosocial aspects and psychiatric disorders in children with thalassemia major. Acta Paediatr Jpn 1997;39:354-7.
Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: Revisited. Blood Cells Mol Dis 2006;37:12-20.
[Table 1], [Table 2], [Table 3], [Table 4]